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Background: Falanga torture (beatings on the foot soles) produces local chronic pain and severe walking
difficulties. We have previously reported signs of neuropathic pain in the feet of falanga victims. The objective here
was to clarify underlying pain mechanisms by quantifying sensory impairments in the feet of torture victims who
had experienced both generalized torture and those who had been exposed to falanga in addition. An ethnically
matched control group was available.
Methods: We employed quantitative sensory testing (QST) by investigators blinded to whether the patients, 32
male torture victims from the Middle East, had (n=15), or had not (n=17) been exposed to falanga. Pain intensity,
area and stimulus dependence were used to characterize the pain as were interview data on sensory symptoms.
QST included thresholds for touch, cold, warmth, cold-pain, heat-pain, deep pressure pain and wind-up to
cutaneous noxious stimuli in the foot soles. Clinical data on anxiety and depression were retrieved.
Results: Almost all falanga victims had moderate or strong pain in their feet and in twice as large an area of their
foot soles as other torture victims. One-third of the latter had no pain in their feet and many reported slight pain;
in spite of this, there were no differences in foot sole QST data between the tortured groups. A comparison with
normal data indicated that both tortured groups had hypoesthesia for all cutaneous sensory fibre groups except
those transmitting cold and heat pain, in addition to deep mechano-nociceptive hyperalgesia.
Conclusion: A comparison of the QST data between victims having been exposed to generalized torture and victims
who in addition had been exposed to falanga, showed no differences on the group level. The sensory disturbances in
relation to our control group are compatible with central sensitization and de-sensitization, pointing to a core role of
central mechanisms. A further analysis to create individual sensory profiles from our measurements is in progress.
Keywords: Chronic pain, Central inhibition, Falanga, Nerve injury, Sensitization, TortureBackground
The use of falanga (beatings on the soles of the feet) is a
torture method which deliberately aims at inflicting in-
tense pain in the feet and lower legs [1,2]. The method
was originally used as legal punishment but is nowadays
used more systematically as a torture method, especially
in the Middle East and the Far East [3]. Years after* Correspondence: bsjolund@health.sdu.dk
2Institute of Public Health, University of Southern Denmark, Odense,
Denmark
Full list of author information is available at the end of the article
© 2012 Prip et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the ortorture the foot pain often persists [2,4,5] and contri-
butes to severe disabilities [6], even when walking mod-
erate distances. Also regarding generalized torture, the
most common physical agent is unspecific beating [3,7].
In addition, it has been found that irrespective of torture
method (physical or mental) the overall sequelae are
similar [8].
The pathophysiological mechanisms of the chronic
pain after falanga have puzzled clinicians and research-
ers. Some have hypothesized that a plantar closed com-
partment syndrome was the cause of pain and resulted. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[2,9,10]. Others have suggested a ruptured plantar apo-
neurosis [11], thickened fascia plantaris [12], or sus-
tained bone trauma [13]. A reduction of the elasticity of
the heel pads has also been proposed [11]. In single
cases, fractures of metatarsal bones and aseptic bone ne-
crosis have been reported [14,15].
Chronic pain is common among torture victims. Olsen
at al. [7] found that more than 80% of patients referred
for rehabilitation of torture sequaele reported chronic
pain. Similar figures have been reported for war veterans
with posttraumatic stress disorders (PTSD) [16]. In
addition, Defrin et al. [17] recently found that persons
with PTSD may have altered sensory processing with a
combination of hypoesthesia and hyperpathia.
It is well known that nerve lesions may cause chronic
neuropathic pain [18]. Thomsen et al. [19] examined 18
torture victims with severe pain to explore the origin of
the pain generation using common bedside neurological
assessment methods. They found a mixture of nociceptive
and neuropathic pain conditions and a relation between
specific neuropathic pain syndromes and exposure to four
common types of torture (beatings all over the body, sus-
pension, falanga and electric torture). Their most notable
finding was the high prevalence of peripheral neuropathy in
falanga victims.
In a group of persons exposed to falanga torture,
we found [5] sensory dysfunction on clinical examin-
ation involving most sensory modalities in the feet
compared to a non-tortured control group, confirm-
ing peripheral nerve lesions after falanga, including
large as well as small sensory fibres. We concluded
that signs of neuropathic pain were present in 10/11
victims and that the sensory findings indicated at
least two neuropathic pain mechanisms: one domi-
nated by a peripheral pain generator and the other by
excitatory phenomena (dysaesthesia) indicating central
sensitization [5].
Extending the observations that neuropathic condi-
tions occur in the feet after falanga torture, the primary
objective of this study was to help clarify the underlying
pain mechanisms [5,20] by quantifying sensory impair-
ments in the feet of two groups of torture victims, all re-
ferred for treatment at the Rehabilitation and Research
Centre for Torture Victims in Copenhagen, Denmark. In
addition, screening data on anxiety and depression were
collected from the patient records. To fulfil the study
objective, we employed quantitative sensory testing
(QST) by investigators blinded to whether our torture
victims had (F), or had not (NF) been exposed to
falanga. We then compared the data between these two
groups and to a separately recruited group of healthy
men with no experience of torture from the Middle
East.Methods
Participants
The patients recruited were torture victims who had
been granted asylum in Denmark. They were all referred
to our centre from their general practitioner, because of
their long-term sequelae from various types of torture
that they had been subjected to several years earlier in
their homeland. The patients were screened by an as-
sessment team (physician, psychologist, physiotherapist
and social worker, supported by an interpreter), with
reference to the centre’s admission criteria: 1) torture vic-
tim with asylum in Denmark; 2) physical, psychological
and social needs; 3) no overt psychosis; 4) no drug or alco-
hol abuse; and 5) available treatment capacity.
Following the main study, by snowball sampling, we
managed to recruit 14 ethnically and age matched healthy
men from the Middle East community in Copenhagen to
form a control group, going through exactly the same
QST methods as the patients. They had lived in Denmark
for an average of 15.8 years (range 7–26), all spoke Danish
and they were integrated and active in the Danish society.
Their mean age was 37 years (range 21–55).
Study selection criteria
The inclusion criteria for this study were tortured male
patients originating from the Middle East speaking their
native language, which was Arabic or Farsi (the majority
of currently referred male patients during the period
May 2009 – June 2010). Seventy-nine consecutively re-
ferred patients were identified via the electronic patient
records (see flowchart in Figure 1). One senior physician
(BHS) screened these medical records and excluded
patients if: they had pathological structural changes in
the feet and lower legs from reasons other than falanga,
for example, fractures, amputations, extensive scar tissue
after burning, cuttings or having foreign objects embed-
ded in the feet/or having been wounded by foreign
objects in the feet, such as shrapnel or bullets; nerve
lesions in the lower legs from other reasons than falanga,
for example, diabetic or alcoholic polyneuropathy and
also injury to the central nervous system such as stroke
or spinal fractures. Twenty-seven persons were excluded,
usually due to injury to the nervous system other than
from falanga. Patients were excluded because of: rhizo-
pathy (n=7), diabetes (n=3), not being mentally fit (n=2),
opioid medication (n=2), spinal fracture (n=1), arterio-
sclerosis in the legs (n=1), hydrocephalus (n=1), not
been tortured but referred for having been secondarily
traumatized (n=3), other problems and were referred for
treatment elsewhere (n=7). Clinical symptoms and signs,
including the typical temporal and anatomical progres-
sion of sensory symptoms of peripheral neuropathy were
always sought for during the clinical history–taking and
examination.
Assessed for eligibility
by independent examiner
(n=79)
Declined to participate
(n=17)
Excluded according to
exclusion criteria
(n=27)
Drop-outs
(n=3)
Exposed to falanga
group analysis 
(n=15)
Not exposed to falanga
group analysis
(n =17)
Blinded examination
(n=35)
Individual analysis
(n=32)
Breaking codes
Figure 1 Flow chart showing the participants’ flow from eligibility to analysis.
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in the study. At individual meetings the examiner (KP)
informed them about the purpose and methods used in
the study. If the patient agreed to participate an
informed consent form was signed and dates for the
assessments arranged. Seventeen turned down the offer,
and three started but dropped out during the test ses-
sions. Thus 32 patients participated in all three sessions.
All participants were offered compensation for travel
expenses. Arabic or Farsi interpreters assisted at all ses-
sions. The project had been carefully introduced to the
three interpreters involved, all of whom had long experi-
ence in interpreting for torture victims. Well informed
about the procedures, they even volunteered for being
tested with the techniques.
Design
The examiner (KP) and a research assistant were blinded
with regard to patient history, diagnosis and whether
falanga torture had occurred or not. Breaking of the blind-
ing took place only after the completion of all examina-
tions and data analyses of the individual patients.Procedure
All examinations were scheduled to 3x2 hour sessions
within a two week period and took place in a quiet room
(stable temperature of 22–24°C) in the research depart-
ment at our centre. For training the various QST methods
were first practiced on healthy Danish volunteers.
We chose to perform the foot assessments on three dif-
ferent days to cause minimal discomfort for the patients.
The 1st session included an interview about pain and other
sensory experiences, location and size of painful area [21]
and foot pain intensity [22], testing of dynamic mechanical
allodynia and dysesthesia in the feet [23]. At the 2nd session
tactile and thermal thresholds were examined [24-28], and
at the 3rd session pressure pain thresholds (PPTs; [28,29])
and wind-up pain upon repeated cutaneous mechano-
nociceptive stimulation [17] were examined. The controls
came only twice since the first session with the in-depth
interview about pain was not necessary; furthermore, these
persons were integrated in the Danish society and thus
time consuming interpretation was not necessary.
In addition, psychological data were retrieved from the
Hospital Anxiety and Depression Scale (HADS; [30]), in
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logical pre-assessment at our clinic. The patient was
instructed to complete the questionnaire in order to rec-
ord how he had felt during the past week. Each question
was read by the psychologist in Danish, translated by the
interpreter according to the Arabic or Farsi HADS ver-
sion, respectively, and the patient marked his response
on the relevant 0–3 Likert-scale. HADS consists of 14
statements that include two subscales. Seven questions
are related to anxiety and seven to depression, each with
a score range of 0–21. Scores 0–7 are regarded as nor-
mal and scores 8–10 are regarded as borderline cases
(mild anxiety and depression) whereas scores above 11–
14 (moderate) and 15–21 (severe) both indicate anxiety
and/or depression.
At all foot examinations the participants lay on a
couch with a special soft mattress. Individual needs were
met to avoid painful body positions and make the pa-
tient as comfortable and relaxed as possible. Applications
of the test stimuli were not visible to the patient at any
time. All assessments and tests were performed by KP. A
research assistant and an interpreter were also present.
Test sites
To our knowledge only few studies have examined the
arch of the foot sole with respect to normal QST values,
and those existing are mostly recorded from the dorsum
of the foot [26,31,32].
Five sites were identified by palpation for examining
mechanical detection thresholds (MDT; [25]) and PPTs;
[29]. They were encircled (10 mm in diameter) with a
soft pen: one proximal to the first metatarso-phalangeal
joint; one at the tuberosity of the calcaneum; one in the
arch of the foot sole under the intermediate cuneiform
bone, one at the lateral border of the sole (distal to the
cuboid bone), and one proximal to the 5th metarso-
phalangeal joint. However, when the patients were asked
which was the most painful area of their foot soles, they
usually answered ‘under the arch’. Therefore, we chose
the arch of the foot sole bilaterally for all remaining
QST sensory tests. This site has been reported to be the
most sensitive in the foot sole, both by our patients and
in the literature [5,27].This choice also made compari-
sons between patients possible.
Assessments
Interview
All participants were asked about pain in the foot soles
at rest and when walking and the findings were regis-
tered on a 3-point Likert scale (0=no pain, 1=slight/
moderate pain, and 2=severe pain; cf. [5]) to determine
activity related changes in foot pain. From these data the
victims’ feet could be divided into three groups: no foot
pain; stimulus-independent foot pain (pain appearingspontaneously at rest); and stimulus-evoked foot pain
(pain evoked by activity, such as when walking) [5].
Reported sensory disturbances such as numbness, cold/
burning, pricking or buzzing sensations were also
registered.
Pain drawings
Two pain drawings were used to assess pain locations
[21]. The examiner (KP) asked the patient to shade in the
locations of their pain on the surface of a body chart
depicting the front and back of a human body and the
painful areas of their feet on a special foot chart (views of
right and left foot soles) [33]. In addition, the patients
were asked to indicate the most painful region of their
body and in both foot soles.The shaded-in areas on the
pain drawings were measured in square millimetres and
calculated in per cent of the total area using a commercial
software program (Quantify One; K:L:O:N:K, Denmark), a
method that has been shown to be reliable for quantifying
pain drawings [34,35].
Pain intensity
Self-reported current pain intensity was assessed on a
visual analogue scale (VAS; 0–100 mm; no pain=0; worst
imaginable pain=100; [22]), with reference to the most
painful body region and to each foot sole separately.
Quantitative sensory testing in the feet
We tested sensory modalities related to all major types
of sensory nerve fibres using QST within the time con-
straints available for these vulnerable patients in both
feet.
A. Mechanical detection thresholds Tactile sensitivity
under the foot soles was assessed bilaterally by measur-
ing the mechanical detection threshold (MDT) to light
touch using Semmes-Weinstein monofilaments (North
Coast Medical, Inc.). We used 17 out of the 20 available
monofilaments, from size 2.83 (target force 0.07 g)
through to size 6.65 (target force 300 g). The detection
threshold was defined as the least force that elicited a
sensation of touch. The monofilament was applied at a
90° angle against the skin until it bowed during 1.5 s,
held for 1.5 s and slowly released during 1.5 s [25]. The
exact threshold was found by performing three repetitive
tests with ascending fibre sizes, until one monofilament
elicited at least one out of three responses (the partici-
pant saying ‘yes’). The next larger filament in size was
applied to confirm the threshold. Regarding the patients,
the detection thresholds were registered for all five sites,
bilaterally. In the controls it was registered in the arch.
The filament size registered was converted into target
force in grams (g) according to a standardized conver-
sion table.
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or unpleasant sensation evoked by a cutaneous mechan-
ical stimulus which does not normally evoke pain. To
examine this phenomenon we used a qualitative test
with light strokes with a soft brush (SENSELabtm–
Brush-05; Somedic, Hörby, Sweden). Three consecutive
strokes were applied with the brush to the skin in the
arch of both foot soles over a 60 mm long distance [23]
and the patient indicated if the stimulus was unpleasant
or painful.
C. Thermal thresholds The thermal tests [24,26,28,36]
were performed to assess cold and warm detection
thresholds (CDT and WDT) and cold and heat pain
thresholds (CPT and HPT) using a TSA 2001 Peltier
stimulator (MEDOC Inc., Israel). The Peltier thermode,
size 3x3cm, was placed on the arch of the foot sole and
attached with full contact to the skin using an elastic
Velcro tape. We used the method of limits [24] and a
baseline temperature of 32°C. The stimulator cut-off
temperatures were set to 0°C for the cold and 50°C for
the warmth assessments, respectively. If the participant
did not respond to the stimulus before the cut-off limit
was reached, this value was registered. The CDT and
WDT were each measured by 4 ramped stimuli (1°C/s;
return rate 1°C/s) and an inter-stimulus interval of 15 s.
The CPT and HPT were also measured by 4 ramped
stimuli (1.5°C/s; return rate 10°C/s) but with an inter-
stimulus interval of 30 s. The participant was carefully
informed about the procedure and instructed to press
the push button the moment a cold/warm sensation was
felt (sensory thresholds) and when the cold/warm stim-
uli became unpleasant or painful (pain thresholds). The
detection thresholds used in the analyses were the mean
values of the 4 stimuli for CDT, WDT, CPT and HPT,
respectively. The skin temperature was measured bilat-
erally in the arch of the foot sole immediately prior to
the thermal tests using a handheld laser FLUKE 62 mini
IR thermometer with a distance of approximately 5 mm
to the skin.
D. Pressure pain thresholds Pressure pain thresholds
(PPTs) were measured to assess deep mechanical noci-
ception [37] by applying pressure to the five test sites bi-
laterally, for the controls the arch. We used an
electronic pressure algometer (Somedic, Höör, Sweden;
[29,38-40]). The algometer probe contact area was 10
mm and covered with 2 mm rubber. The instrument
was calibrated to a zero level before each session. A pre-
test was performed bilaterally on the radio-humeral ex-
tensor muscle group approximately 10 cm distal to the
radio-humeral joint to familiarize the patient with the
procedure. The most painful area reported in the foot
soles was measured last in each series to avoid evokingdiscomfort. Always starting with the right foot sole, the
examiner applied alternating series of three measure-
ments on the five sites. A gradual pressure was applied
vertical to the skin area and increased at a speed of 40
kPa/s controlled via monitoring on a display. The inter-
stimulus interval was 30 s, and the inter-series interval
5 min. A cut-off was set at 900 kPa/s to avoid tissue
damage [37]. The participant was instructed to press the
push button when a sensation of pain or discomfort was
perceived and the pressure ceased immediately. The
PPT value, expressed in kPa/s, was the mean value of
the last two sessions for each of the sites [39].
E. Temporal summation of mechano-nociceptive
stimuli (wind-up pain) Wind-up pain [41-44] refers to
central pain sensitization caused by repeated painful
stimulation of peripheral nerves at sufficient intensity to
stimulate C-fibres, leading to progressively increasing re-
sponse in the corresponding spinal posterior horn neu-
rons. For this measure we used the thickest available
Semmes-Weinstein monofilament (size 6.65; [45]). At
0.3 Hz the examiner applied the filament four consecu-
tive times to the surface of the skin in the arch of each
foot sole. The patients were asked to rate the pain inten-
sity on a VAS after the 1st and 4th stimulus. A 5-minute
pause followed. Thereafter, to produce a more intense
stimulation, 10 consecutive stimuli were applied at the
rate of 1.0 Hz. The patients rated their pain after the 1st
and 10th stimulus. If the VAS difference between the 1st
and last stimulus was positive, a temporal summation
(wind-up) had occurred.
Statistics
We chose to analyse the data from the right and left feet
separately, since they may share common analysis
mechanisms in the central nervous system, even if separ-
ate. The mean, SD, 95% CI, median, and range were cal-
culated for all ten variables, as were the correlations
between both feet. Students t-test or Fisher’s exact test
was used to test for differences between sides.
To detect differences between the torture groups and
the controls, identified after breaking the blinding as vic-
tims not exposed to falanga (NF) and victims exposed to
falanga (F), we used univariate ANOVA’s test. A post hoc
Tukey analysis was performed to indicate the differences
between data in the respective groups. Acceptable p-values
were set to ≤0.05.
The data were analysed using the Statistical Package
for Social Sciences (SPSS) version 18, Software for Win-
dows (SPSS, Chicago; IL; USA).
Ethics
Each participant was informed verbally about the study
and was also given an information kit containing a
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respective languages. They also received translated
guidelines concerning participation in medical research
issued by the Danish Ethical Committee. The assess-
ments comply with the Helsinki II Declaration [46] and
the patients could withdraw from the study at any time,
without any impact on their planned rehabilitation at
our clinic. The study was approved by the Research Eth-
ics Committee in Region Copenhagen, Denmark (H-D-
2009-068) and registered at the Danish Data Protection
Agency.
Results
Patient characteristics
Figure 1 illustrates that 79 consecutive patients were
identified as eligible to participate in the study. Twenty-
seven patients were excluded due to: rhizopathy (n=7),
diabetes (n=3), not being mentally fit (n=2), opioid
medication (n=2), spinal fracture (n=1), not tortured but
referred for having been secondarily traumatized (n=3),
arteriosclerosis in the legs (n=1), hydrocephalus (n=1),
or referred for treatment elsewhere (n=7). Seventeen
declined to participate and three dropped out; thus 32
patients participated in all three test sessions. When
breaking the blinding, it turned out that 17 patients had
not been exposed to falanga (NF) and 15 had been
exposed to falanga (F). Of the 20 patients that declined
to participate or dropped out, 9 had been exposed to
falanga.
The mean age did not differ between the two groups:
NF = 44.5 years (range 34–63) and F = 46.3 years (range
38–55). The NF victims had been tortured for the first
time during the years 1979–2000 and had spent a me-
dian of 180 days (range 1–2372) in prison, whereas the F
victims had been tortured for the first time during the
years 1989–1996 and had spent a median of 365 days
(range 15–1700) in prison.Table 1 Right vs. left feet similarities regarding pain characte
and the 14 controls
Pain intensity
VAS
Pain area %
of foot sole
MDT target
force
CD
Torture victims right/left feet
Pearson correlation
(p-value)
0.798
(<0.001)
0.730
(<0.001)
0.525
(0.002)
0.84
(<0.0
Student’s t-test
p-value
0.104 0.229 0.108 0.38
Controls right/left feet
Pearson correlation
(p-value)
0.841
(<0.001)
0.82
(<0.0
Student’s t-test
p-value
0.170 0.89
VAS, visual analogue scale; MDT, mechanical detection threshold; CDT, cold detectio
heat pain threshold; PPT, pressure pain threshold; Wind-up mm at 0.3 Hz (mean pre
Wind-up mm at 1.0 Hz (mean pre/post difference in pain intensity VAS mm after wAll 32 patients reported pain in many parts of the
body, located in at least 3 out of 4 quadrants. When
asked about their one most painful region, neck, shoul-
der and low-back pain were the most common com-
plaints, and only two patients in the F group reported
their foot pain as being the most severe. The mean body
pain area size in the NF patients was 13.8% of the total
body area (median 11%; range 2-39%) whereas for the F
patients it was 21.0% (median 14.0%; range 4-57%). The
mean current body pain intensity (VAS) in the NF
patients was 48 mm (median 44; range 15–100 mm)
whereas for the F patients it was 60 mm (median 55;
range 23–100 mm). Neither of these differences was sig-
nificant (Student’s t-test).
Since we could collect data from 64 feet but the cen-
tral pain processing occurred in 32 persons, we exam-
ined whether QST data from the two sides of a single
individual corresponded. It turned out that the Pearson
correlation coefficient from the right versus left data of
the torture victims was generally high (Table 1) and the
t-test did not show any significant difference between
the sides. The same held for the control data (Table 1).
It was possible to retrieve data on anxiety and depres-
sion in 26 out of our 32 patients (NF=12; F=14) from
HADS forms. The median anxiety score in NF victims
was 19.5 points (11 out of 12 patients had ≥ 15 points)
and in F victims was 19.0 points (13 out of 14 patients
had ≥ 15 points) demonstrating severe anxiety in both
groups. The median depression score in NF victims was
16.5 points (8 out of 12 patients had ≥ 15 points) ) and in
F victims was 17 points (10 out of 14 patients had ≥ 15
points), likewise pointing to severe depression.
Pain conditions in the feet
Pain characteristics
The 32 patients were categorized according to their
reported activity related foot pain when walking. Sevenristics and sensory functions for the 32 torture victims
T WDT CPT HPT PPT Wind-up
at 0.3 Hz
Wind-up
at 1.0 Hz
7
01)
0.783
(<0.001)
0.809
(<0.001)
0.738
(<0.001)
0.818
(<0.001)
0.036
(0.053)
0.724
(<0.001)
6 0.281 0.413 0.315 0.529 0.215 0.088
4
01)
0.550
(0.041)
0.817
(<0.001)
0.726
(0.003)
0.920
(<0.001)
0.643
(0.013)
0.944
(<0.001)
7 0.312 0.065 0.646 0.147 0.981 0.158
n threshold; WDT, warm detection threshold; CPT, cold pain threshold; HPT,
/post difference in pain intensity VAS mm after wind-up stimulation at 0.3 Hz);
ind-up stimulation at 1.0 Hz).
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pain, whereas stimulus-evoked pain was perceived in 45
feet (NF/F: 20/25). No pain was reported in 12 feet (NF/F:
10/2). Thus only 2/30 F feet were pain free whereas 10/34
NF feet were so (p=0.062; Fisher’s exact test). A corre-
sponding comparison between pain free feet and those
with stimulus-evoked pain (NF/F: 10/2 vs. 20/25) was
barely significant (p=0.023; Fisher’s exact test).
Current foot pain intensity at rest was ≤ 30 mm (VAS
‘slight pain’; [47]) in 20/34 feet of the NF patients
whereas 17/28 patients in the F group had moderate or
severe pain (VAS > 30 mm). The mean pain area cov-
ered 21% of the foot sole in the NF group; however, in
the F group it was 44%, a highly significant difference
(p<0.001; Student’s t-test).
Reported sensory disturbances
From the interviews regarding the 64 feet (relation NF/F
34/30 feet), numbness was experienced in 21/14 feet;Table 2 Sensory function in the right foot of 15 falanga (F) an
controls (C) (mean, SD, 95% CI, median and range for eight Q
Right foot MDT CDT WDT
target force g °C °C
Mean Mean Mean
SD SD SD
CI CI CI
Median Median Median
(Range) (Range) (Range)
Falanga n=15 5.66 25.2 43.2
15.22 4.8 4.9
−2.77–14.09 22.5–27.9 40.5–45.9
1.00 27.0 44.5
(0.16–60.00) (14.4–30.7) (35.5–50.0)
No Falanga n=17 3.71 22.5 44.2
4.62 7.7 4.7
1.33–6.09 18.4–26.5 41.7–46.7
1.00 24.8 44.6
(0.07–15.00) (0–29.4) (34.0–50.0)
Controls n=14 0.41 28.0 40.1
0.35 2.4 2.8
0.21–0.61 26.6–29.4 38.5–41.7
0.28 28.8 40.3
(0.07–1.00) (20.9–30.1) (35.3–43.3)
ANOVA p-value 0.010 * 0.019 0.030
Tukey’s post hoc test F/NF 0.880 * 0.278 0.791
F/C 0.043 * 0.361 0.128
NF/C 0.011 * 0.014 0.027
MDT, mechanical detection threshold; g, gram; CDT, cold detection threshold; WDT
PPT, pressure pain threshold; kPa, kiloPascal; Wind-up mm at 0.3 Hz (mean pre/pos
Wind-up mm at 1.0 Hz (mean pre/post difference in pain intensity VAS mm after wcold sensation in17/12 feet; burning sensation in 20/22
feet and a pricking sensation in 17/20 feet, respectively.
The brush test (NF/F) demonstrated dysesthesia in 15/14
feet, and dynamic mechanical allodynia in 4/2 feet. Thus,
there were no obvious differences between those exposed
to falanga or not regarding irritative phenomena.QST in the feet
As can be seen in Tables 2 and 3 an ANOVA analysis
with Tukey’s post hoc test of all data showed no signifi-
cant QST differences between the two torture groups.
However, in relation to the control values there was sig-
nificant hypoesthesia for mechanical thresholds (MDT)
and hyperalgesia for deep mechanical nociception (PPT)
in the two groups, whether exposed to falanga or not.
Cold (CDT) and warm detection (WDT) were signifi-
cantly impaired compared to controls but only in the no
falanga group (Tables 2 and 3).d 17 no falanga (NF) torture victims and 14 healthy
ST variables)
CPT HPT PPT Wind-up mm Wind-up mm
°C °C kPa at 0.3 Hz at 1.0 Hz
Mean Mean Mean Mean Mean
SD SD SD SD SD
CI CI CI CI CI
Median Median Median Median Median
(Range) (Range) (Range) (Range) (Range)
19.1 47.0 252 16 29
9.2 4.6 206 20 23
14.0–24.2 44.5–49.6 138–365 4–28 16–43
21.7 49.9 181 10 27
(0–29.2) (37.9-50.0) (19–833) (−3–72) (0–82)
15.3 48.9 275 5 27
9.7 1.8 205 8 18
9.9–20.6 47.9–49.9 169–380 1–9 17–36
18.5 50.0 214 2 35
(0–26.3) (44.3–50.0) (98–818) (−4–23) (0–51)
18.2 46.7 485 17 30
8.3 2.5 179 14 19
13.5–23.0 45.3–48.2 381–588 9–25 18–41
21.2 46.8 460 17 28
(2.6–27.7) (42.4–50.0) (240–912) (−3–45) (0–62)
0.505 0.150 0.005 0.050 0.924
0.507 0.264 0.941 0.122 0.949
0.967 0.964 0.008 0.970 0.999
0.673 0.176 0.014 0.067 0.930
, warm detection threshold; CPT, cold pain threshold; HPT, heat pain threshold;
t difference in pain intensity VAS mm after wind-up stimulation at 0.3 Hz);
ind-up stimulation at 1.0 Hz); * calculated on log MDT.
Table 3 Sensory function in the left foot of 15 falanga (F) and 17 no falanga (NF) torture victims and 14 healthy
controls (C) (mean, SD, 95% CI, median and range for eight QST variables)
Left foot MDT CDT WDT CPT HPT PPT Wind-up mm Wind-up mm
target force g °C °C °C °C kPa at 0.3 Hz at 1.0 Hz
Mean Mean Mean Mean Mean Mean Mean Mean
SD SD SD SD SD SD SD SD
CI CI CI CI CI CI CI CI
Median Median Median Median Median Median Median Median
(Range) (Range) (Range) (Range) (Range) (Range) (Range) (Range)
Falanga n=15 33.98 24.4 43.5 20.6 47.6 239 6 26
86.70 7.6 4.1 7.3 3.9 142 21 25
−14.03–82.00 20.2–28.7 41.2–45.8 16.5–24.6 45.5–49.8 160–317 −7–19 11–42
1.40 27.9 43.8 20.2 49.5 209 10 20
(0.16–300.00) (0–30.1) (36.0–50.0) (0–29.1) (36.5–50.0) (78–488) (−50–35) (0–78)
No Falanga n=17 9.47 21.9 45.1 15.5 49.2 262 6 20
16.17 7.5 3.5 9.6 1.4 179 12 16
1.16–17.79 17.9–25.9 43.2–46.9 10.2–20.8 48.4–50.0 170–353 −1–12 12–29
2.00 24.3 45.5 19.7 50.0 210 3 21
(0.07–60.00) (0–29.4) (39.1–50.0) (0–27.8) (45.0–50.0) (94–745) (−14–29) (−1–50)
Controls n=14 0.33 28.0 40.9 21.1 47.0 456 17 27
0.34 2.4 3.1 4.7 2.5 167 13 22
0.14-0.53 26.6–29.3 39.1–42.7 18.3–23.8 45.5–48.4 359–552 10–24 14–39
0.16 28.9 41.3 20.6 47.6 461 18 26
(0.07–1.00) (21.6–30.2) (36.1–45.1) (9.2–27.9) (42.0–49.8) (208–783) (0–39) (−2–63)
ANOVA p-value 0.002 * 0.045 0.011 0.099 0.093 0.001 0.096 6.656
Tukey’s post hoc test F/NF 0.919 * 0.518 0.444 0.172 0.278 0.918 0.996 0.725
F/C 0.003 * 0.314 0.143 0.983 0.794 0.003 0.163 1.000
NF/C 0.007 * 0.035 0.008 0.130 0.088 0.006 0.123 0.701
MDT, mechanical detection threshold; g, gram; CDT, cold detection threshold; WDT, warm detection threshold; CPT, cold pain threshold; HPT, heat pain threshold;
PPT, pressure pain threshold; kPa, kiloPascal; Wind-up mm at 0.3 Hz (mean pre/post difference in pain intensity VAS mm after wind-up stimulation at 0.3 Hz);
Wind-up mm at 1.0 Hz (mean pre/post difference in pain intensity VAS mm after wind-up stimulation at 1.0 Hz); * calculated on log MDT.
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temperature was measured and the mean was found to
be 30.8°C (NF) and 30.4°C (F), similar to values found in
the literature [48]. During the measurements we had to
stop the thermal test for two NF victims, once for psy-
chological reasons and once because the pain became
unbearable, spreading upwards in both lower legs. This
pain condition lasted into the following day, probably
due to temporal summation.
The mean pre/post difference in pain intensity for the
F group after repeated cutaneous mechanical stimula-
tion at 0.3 Hz (cf. [17]) was 16 mm for the right foot
and 6 mm for the left foot, twice that of the NF group
(5–6 mm) but not, however, statistically different. A
more intense “wind-up” stimulation with 10 stimuli at
1.0 Hz produced about equal temporal summation in
both groups (VAS mean pre/post difference for F=29 mm
and for NF=27 mm for the right foot and for the left foot26–20 mm). However, the wind-up effect was about the
same in both feet of the controls as in the falanga group
(Tables 2 and 3).Possible influence of the mental state
Using correlation analysis we also explored other va-
riables to explain our findings and found a clear cor-
relation between the severity of HADS anxiety score
and foot pain intensity (all feet; r=0.44; p=0.001;
Spearman’s test). Regarding body pain intensity, only
a tendency to correlation was seen (r=0.38; p=0.059).
The same was found for body pain area size (r=0.39;
p=0.047). There were no correlations between bo-
dy pain intensity/body pain area size and the
HADS depression scores. Regarding the QST vari-
ables, there were no significant correlations to HADS
scores at all.
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Pain and sensory function
We compared the sensory findings from victims exposed
to generalized torture to victims who had additionally
been exposed to falanga, as an extension to earlier stud-
ies from our centre [5,6,19]. In addition, we examined
an ethnically matched healthy control group with the
same QST tests for comparison. After breaking the
blinding, the share of victims not exposed to falanga
(NF) and victims exposed to falanga (F) turned out to be
about the same (Figure 1). This finding was unexpected,
since from earlier studies [6], most torture victims from
the Middle East have been beaten under the feet [3].
In spite of the expected clinical differences in foot pain
symptoms between the two tortured groups, our main
observation was that there were no significant differ-
ences between them regarding the QST findings. How-
ever, in comparison to our control data, the picture is
instead dominated by a generalized hyposensitivity to
non-noxious cutaneous stimuli in the foot soles in com-
bination with deep mechanical hyperalgesia. A possible
interpretation of these unexpected findings could be that
the impact of generalized torture is so heavy on the cen-
tral nervous system that the situation of the individual is
dominated by a global change in central function. This
would consist of a blend of sensory sensitization (deep
mechanical hyperalgesia; [49]), de-sensitization (cutane-
ous hypoesthesia; [17]) and mental changes like strong
anxiety and depression. It should be remembered that
patients are referred to our centre because they experi-
ence physical, psychological and social sequelae from
torture. Hence, many of them (56%; [50]) suffer from
complex PTSD or ‘disorders of extreme stress not other-
wise specified’ (DESNOS; [51]) which may indeed influ-
ence central nervous system function [17]. Thus, the
influence of the local trauma against the foot soles
(falanga) seems to be too small to be detected by the
QST techniques under these circumstances.
The elevated MDTs indicate that both groups had
reduced protective sensation. According to Bell-Krotoski
[25] the 2.83 filament (target force 0.07 g) is optimal for
detection of mechanical stimuli in most body areas with
the exception of the foot sole, where a slightly stronger
filament 3.61 (0.4 g) is recommended for normal sub-
jects. We had to use a much stronger filament to obtain
a response indicating hypoesthesia due to a partial loss
of function in the Aβ-fibres [28,52].
HPTs and CPTs were within normal range in both
groups of torture victims. Regarding PPTs, we found
hyperalgesia to deep mechanical stimuli in both groups,
probably due to a central sensitization, or possibly due
to peripheral sensitization of C-fibre nociceptors [37].
In a sense, our QST findings comply well with the
results of researchers studying other neuropathic painconditions. Their study results have been found to com-
prise a complex web of different pain and sensory char-
acteristics [49,53-57] rather than consistent findings
related to a particular causative factor, in our case a re-
petitive mechanical trauma. In the clinical situation it
may therefore be important, as recommended by several
authors [52,57-59] to examine each person’s sensory
profile as various sensory symptoms differ between
individuals.
The only previous study of chronic pain in patients
suffering from PTSD was conducted by Defrin et al.
[17]. They found a higher prevalence of chronic pain
compared to a group with common anxiety disorder and
a significant correlation between chronic pain intensity
and PTSD severity. This observation fits with our find-
ing of a significant correlation between the HADS anx-
iety scores and foot pain intensity (VAS). Furthermore,
they found that QST revealed higher MDT, WDT and
HPT and lower CDT in the PTSD cases compared to
those with anxiety disorder and normal subjects. Their
three groups (PTSD, anxiety disorders and healthy con-
trols) exhibited a temporal summation following mech-
anical stimulation at 0.3 Hz, but the PTSD subjects
scored slightly higher. Conversely, our patients showed
little or control-size wind-up when using the parameters
of Defrin et al., which could be due to central changes.
Defrin et al. [17] attributed their findings to the manner
in which PTSD subjects emotionally interpret and re-
spond to pain stimuli. At variance with this interpret-
ation, we found little or no correlation between pain
characteristics and QST data and the degree of depres-
sion or anxiety in our patients. It is reasonable to as-
sume that all our patients had sustained a combination
of physical and psychological trauma producing a less
clear picture.
Study limitations
Regarding the study subjects
The patients were refugees with residence permit in Den-
mark and referred by their general practitioner to our spe-
cialized clinic, making our sample highly selected and
therefore probably not representative of all torture victims.
With our traumatized patients, it was not possible to
collect exact information on the extent of falanga tor-
ture, that is, how often and how severely the victims had
been beaten. Attempts to retrieve such information may
produce intense anxiety and flash backs. Moreover, all
patients had been subjected to various forms of torture,
usually during extended periods of detention, increasing
the risk of brain injuries [60], which may contribute to
the pain reported. Torture victims are vulnerable, often
forget and have difficulties to focus attention [51]. Using
QST requires cooperation from the patient and the
dimensions of cognitive effects on QST findings are not
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chronic widespread pain is associated with lower cogni-
tive processing speed [63]. The psychophysical nature of
the QST data may have been influenced by the high
levels of anxiety and depression present in our patients.
However, we found no correlations to single QST vari-
ables and the consistent mixture of hypoesthesia and
hyperalgesia speaks against such a general effect.
Since many of these patients have been imprisoned for
long time periods, it is important to distinguish the
present findings from those elicited by peripheral neur-
opathy, whether from toxic, nutritional or infectious
causes. However, the victims were carefully examined
for such comorbidities during the medical assessment
(see Methods) and secondly, motor deficits, typical for
severe polyneuropathies, were never found among the
included patients. Furthermore, the combination seen in
our patients, cutaneous hypoesthesia, normal nocicep-
tive transmission and deep mechanical hyperalgesia, is
not typical for peripheral neuropathies but has been
reported in, for example, chronic regional pain syn-
drome (Appendix A in [49]). Nevertheless, a component
of sensory neuropathy in the torture victims cannot be
completely excluded.
Regarding the QST techniques
Recently there has been a debate on whether QST is of
value in assessing sensory disturbances in single patients
[58,64]. The consensus seems to be that QST, although
demonstrating a high specificity, has a low sensitivity
that does not always pick up discrete sensory abnormal-
ities as well as the clinical examination does. In the
present study it cannot be ruled out that minor signs of
nerve injury in the foot soles were not detected by our
QST measurements, which may explain the discrepancy
with our previous clinical study [5]. It may also be that
individual variations make the heterogeneity within
groups too big to demonstrate group differences. We will
therefore continue the QST analysis by producing individ-
ual sensory profiles for all participants, containing both
sensory symptoms and QST data [49,53,57,58,65,66].
Conclusion
In conclusion, a comparison of the QST data between
victims having been exposed to generalized torture and
victims who in addition had been exposed to falanga,
unexpectedly showed no differences at the group level.
This was so even though almost all the falanga victims
had moderate to strong pain in their feet and in twice as
large an area of their foot soles as the torture victims
not exposed to falanga. One-third of the latter did not
report pain in their feet at all and many reported only
slight pain. On the other hand, the comparison to our
normal data indicated that there was hyperalgesia todeep mechano-nociceptive stimuli, irrespective of expos-
ure to falanga or to other forms of torture. In addition,
the cutaneous sensory fibre groups, except those trans-
mitting cold and heat pain, were less sensitive to exter-
nal stimuli. The findings are compatible with central
sensitization and de-sensitization, pointing to a core role
of central mechanisms. One way to strengthen the ana-
lysis is to create sensory profiles from our data on the
individual level, which has been done in the subsequent
paper [66].
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